Sign up to save your podcasts
Or
Share 🎙️ Episode 38: TXA for ICH: Not the Magic Bullet
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
🎙️ Episode 38: TXA for ICH: Not the Magic Bullet
Send us a text
🧪 Study:
TXA within 2 hrs of ICH did not reduce hematoma expansion.
No benefit in functional outcome or mortality.
⚠️ Note:
Slight ↑ in thromboembolic events (3% vs 1%).
🧩 Clinical Takeaway:
No routine use for TXA in spontaneous ICH.
Still potential niche use in select trauma cases.
View all episodes
By Brilliant Board Review & CMESend us a text
🧪 Study:
TXA within 2 hrs of ICH did not reduce hematoma expansion.
No benefit in functional outcome or mortality.
⚠️ Note:
Slight ↑ in thromboembolic events (3% vs 1%).
🧩 Clinical Takeaway:
No routine use for TXA in spontaneous ICH.
Still potential niche use in select trauma cases.